Minimal important difference to infer changes in health-related quality of life-a systematic review.

[1]  Norbert Kovács,et al.  Minimal clinically important difference on the Motor Examination part of MDS-UPDRS. , 2015, Parkinsonism & related disorders.

[2]  J. Aviña-Zubieta,et al.  Approaches for estimating minimal clinically important differences in systemic lupus erythematosus , 2015, Arthritis Research & Therapy.

[3]  R. Lewis,et al.  Minimal clinically important difference: defining what really matters to patients. , 2014, JAMA.

[4]  A. Garratt,et al.  Comparative responsiveness and minimal change of the Knee Quality of Life 26-item (KQoL-26) questionnaire , 2013, Quality of Life Research.

[5]  Alexis Wright,et al.  Clinimetrics corner: a closer look at the minimal clinically important difference (MCID) , 2012, The Journal of manual & manipulative therapy.

[6]  D. Osoba,et al.  Minimal clinically meaningful differences for the EORTC QLQ-C30 and EORTC QLQ-BN20 scales in brain cancer patients. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

[7]  C. Terwee,et al.  Rating the methodological quality in systematic reviews of studies on measurement properties: a scoring system for the COSMIN checklist , 2011, Quality of Life Research.

[8]  M. King.  A point of minimal important difference (MID): a critique of terminology and methods , 2011, Expert review of pharmacoeconomics & outcomes research.

[9]  P. McNair,et al.  Responsiveness, minimal importance difference and minimal detectable change scores of the shortened disability arm shoulder hand (QuickDASH) questionnaire. , 2010, Manual therapy.

[10]  C. Terwee,et al.  The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. , 2010, Journal of clinical epidemiology.

[11]  Ronald C. Chen,et al.  Individualizing quality-of-life outcomes reporting: how localized prostate cancer treatments affect patients with different levels of baseline urinary, bowel, and sexual function. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement , 2009, BMJ : British Medical Journal.

[13]  M. McKay,et al.  Targeted plasma proteome profiling for early prediction of chemotherapy response and toxicity in colorectal cancer (CRC). , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  G. Guyatt,et al.  Qualiveen, a urinary-disorder specific instrument: 0.5 corresponds to the minimal important difference. , 2008, Journal of clinical epidemiology.

[15]  R. Hays,et al.  Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. , 2008, Journal of clinical epidemiology.

[16]  Roger L. Brown,et al.  Comparison of anchor-based and distributional approaches in estimating important difference in common cold , 2008, Quality of Life Research.

[17]  G. Guyatt,et al.  The impact of measuring patient-reported outcomes in clinical practice: a systematic review of the literature , 2008, Quality of Life Research.

[18]  C. Gotay,et al.  Patient‐reported Outcomes in Cancer: A Review of Recent Research and Policy Initiatives , 2007, CA: a cancer journal for clinicians.

[19]  A. Copay,et al.  Understanding the minimum clinically important difference: a review of concepts and methods. , 2007, The spine journal : official journal of the North American Spine Society.

[20]  G. Guyatt,et al.  How can quality of life researchers make their work more useful to health workers and their patients? , 2007, Quality of Life Research.

[21]  S. Hogg-Johnson,et al.  Three methods for minimally important difference: no relationship was found with the net proportion of patients improving. , 2007, Journal of clinical epidemiology.

[22]  J. Kaufman,et al.  Four methods of estimating the minimal important difference score were compared to establish a clinically significant change in Headache Impact Test. , 2006, Journal of clinical epidemiology.

[23]  A. Kulkarni,et al.  Distribution-based and anchor-based approaches provided different interpretability estimates for the Hydrocephalus Outcome Questionnaire. , 2006, Journal of clinical epidemiology.

[24]  Roger L. Brown,et al.  Sufficiently Important Difference: Expanding the Framework of Clinical Significance , 2005, Medical decision making : an international journal of the Society for Medical Decision Making.

[25]  Ajit N Babu,et al.  A comparison of clinically important differences in health-related quality of life for patients with chronic lung disease, asthma, or heart disease. , 2005, Health services research.

[26]  K. Wyrwich.  Minimal Important Difference Thresholds and the Standard Error of Measurement: Is There a Connection? , 2004, Journal of biopharmaceutical statistics.

[27]  R. P. Di Fabio,et al.  Reliable change and minimum important difference (MID) proportions facilitated group responsiveness comparisons using individual threshold criteria. , 2004, Journal of clinical epidemiology.

[28]  D. Neuberg,et al.  A combination of distribution- and anchor-based approaches determined minimally important differences (MIDs) for four endpoints in a breast cancer scale. , 2004, Journal of clinical epidemiology.

[29]  Ross D Crosby,et al.  Defining clinically meaningful change in health-related quality of life. , 2003, Journal of clinical epidemiology.

[30]  G. Norman,et al.  Interpretation of Changes in Health-related Quality of Life: The Remarkable Universality of Half a Standard Deviation , 2003, Medical care.

[31]  D. Cella,et al.  Combining anchor and distribution-based methods to derive minimal clinically important differences on the Functional Assessment of Cancer Therapy (FACT) anemia and fatigue scales. , 2002, Journal of pain and symptom management.

[32]  Gordon H Guyatt,et al.  Methods to explain the clinical significance of health status measures. , 2002, Mayo Clinic proceedings.

[33]  D. Cella,et al.  What is a clinically meaningful change on the Functional Assessment of Cancer Therapy-Lung (FACT-L) Questionnaire? Results from Eastern Cooperative Oncology Group (ECOG) Study 5592. , 2002, Journal of clinical epidemiology.

[34]  D. Beaton,et al.  Many faces of the minimal clinically important difference (MCID): a literature review and directions for future research. , 2002, Current opinion in rheumatology.

[35]  G. Guyatt,et al.  Relation of Distribution- and Anchor-Based Approaches in Interpretation of Changes in Health-Related Quality of Life , 2001, Medical care.

[36]  B Shea,et al.  Minimal clinically important differences: review of methods. , 2001, The Journal of rheumatology.

[37]  D. Patrick,et al.  Measurement of Health Outcomes in Treatment Effectiveness Evaluations: Conceptual and Methodological Challenges , 2000, Medical care.

[38]  M. Liang.  Longitudinal Construct Validity: Establishment of Clinical Meaning in Patient Evaluative Instruments , 2000, Medical care.

[39]  P. Fayers,et al.  Quality of Life: Assessment, Analysis, and Interpretation , 2000 .

[40]  W. Tierney,et al.  Further evidence supporting an SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life. , 1999, Journal of clinical epidemiology.

[41]  A. Laupacis,et al.  Surveying physicians to determine the minimal important difference: implications for sample-size calculation. , 1999, Journal of clinical epidemiology.

[42]  G. Guyatt,et al.  Assessing the minimal important difference in symptoms: a comparison of two techniques. , 1996, Journal of clinical epidemiology.

[43]  G. Guyatt,et al.  Interpreting changes in quality-of-life score in N of 1 randomized trials. , 1991, Controlled clinical trials.

[44]  G. Guyatt,et al.  Measurement of health status. Ascertaining the minimal clinically important difference. , 1989, Controlled clinical trials.

[45]  Lewis E. Kazis,et al.  Effect Sizes for Interpreting Changes in Health Status , 1989, Medical care.

[46]  L. Bero,et al.  The Food and Drug Administration reports provided more data but were more difficult to use than the European Medicines Agency reports. , 2015, Journal of clinical epidemiology.

[47]  K. Jordan,et al.  A minimal clinically important difference was derived for the Roland-Morris Disability Questionnaire for low back pain. , 2006, Journal of clinical epidemiology.

[48]  D. Osoba,et al.  Interpreting the significance of changes in health-related quality-of-life scores. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[49]  G H Guyatt,et al.  Determining a minimal important change in a disease-specific Quality of Life Questionnaire. , 1994, Journal of clinical epidemiology.